Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BofA Securities released a report stating that Nvidia has once again delivered strong results and raised guidance. Although the midpoint of revenue guidance for the second fiscal quarter ending in late July is $91 billion, which is in line with market expectations, this has led to typical post-market volatility. In the past four earnings releases, the stock price has fallen three times after results.

BofA Securities released a report stating that Nvidia has once again delivered strong results and raised guidance. Although the midpoint of revenue guidance for the second fiscal quarter ending in late July is $91 billion, which is in line with market expectations, this has led to typical post-market volatility. In the past four earnings releases, the stock price has fallen three times after results.

老虎证券老虎证券2026/05/22 03:11
Show original
However, the bank points out that, setting aside this noise, the focus should be on NVIDIA's following advantages: the total addressable market (TAM) for AI is expected to grow fourfold over the next four years, surpassing 3 trillion USD by 2030 (previously forecasted at 1.7 trillion USD), with NVIDIA possessing a unique full-stack positioning; industry-leading gross margin of 75%, free cash flow profit margin at around 48%, while significantly raising dividend by 25 times to 0.45%, and planning to repurchase approximately 120 billion USD in shares; demonstrating new leadership in the proxy CPU market, with 20 billion USD in demand already observed for the second half of fiscal 2026, and related memory and wafer capacity already reserved. The bank has raised its earnings per share forecasts for NVIDIA for fiscal 2027 and 2028 by 9% and 15% respectively, to 9.09 USD and 13.27 USD, and has increased the target price from 320 USD to 350 USD, maintaining a “Buy” rating.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11